HOME >> BIOLOGY >> NEWS
Researchers will study cell growth, differentiation

A grant from the G. Harold & Leila Y. Mathers Charitable Foundation will help scientists at the University of Washingtons Cell Systems Initiative build a prototype to study how cells grow, proliferate and differentiate.

"A fundamental problem in cell systems is to understand the information control processes that enable commands encoded within the DNA to be expressed and for that genomic data to be reprogrammed during development. We expect to develop tools that will prove crucial to a better understanding of biology and medicine a platform for the study of molecular networked events as they occur in the changing conditions of a living cell," says Dr. Bob Franza, director of CSI and a research professor in the UWs departments of bioengineering and genome sciences.

There are many uses for better knowledge of cell systems. Someday, researchers might be able to develop more effective drugs and know in advance how a particular drug will work within a cell. The modeling could be done on a computer without initial tests on humans.

CSI, part of the Department of Bioengineering and School of Medicine, is a research and educational initiative whose mission is to understand the dynamic information systems in cells. CSI includes industry and academic participants in collaborative research studies, focused on integrating genomic and functional information, powerful bioinformatics and novel experimental techniques to expand understanding of human disease. CSIs private associates include Immunex Corp. and Isis Pharmaceuticals.

With the $756,000 Mathers grant, CSI hopes to develop a prototype of an observation platform that will allow real-time measurement of complex processes within the cell.

The operations of a cell are unbelievably complicated. "We are developing a technology platform that has the versatility and flexibility required for the analysis of complex regulatory networks," Franza says. "This revolutionar
'"/>

Contact: Walter Neary
wneary@u.washington.edu
206-685-3841
University of Washington
12-Mar-2002


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: